Celiac Disease Eligible for CMDRP Research Funding for the First Time – Marilyn’s Message January 2023
2023 promises to be a year full of robust research, advocacy, and education efforts on behalf of our patient community.
Continue Reading2023 promises to be a year full of robust research, advocacy, and education efforts on behalf of our patient community.
Continue ReadingAs Thanksgiving approaches, we at the Celiac Disease Foundation are grateful for you, our celiac community, and the progress we are making – together – to accelerate diagnosis, treatment, and a cure for celiac disease.
Continue ReadingThere is overwhelming scientific evidence that poor nutrition contributes to dozens of diseases, including many cancers, diabetes, heart disease, and obesity. Everyone, including government and the food industry, has a role to play in changing this fact.
Continue ReadingThe need for action is clear. The failure to understand and treat celiac disease appropriately manifests in low rates of diagnosis, lack of research funding and alternative treatments, and limited understanding of the economic and social costs of this disease.
Continue ReadingAs a result of our work, we are pleased to announce that the Celiac Disease Foundation will host an Ask-the-FDA Educational Webinar on October 13, 2022.
Continue ReadingAccelerating research for treatments and a cure for celiac disease is the top priority of the Celiac Disease Foundation. We are optimistic that the current surge of research will produce…
Continue ReadingWith the 9 Meters decision to halt the CedLara Phase 3 trial because of the cost of patient recruitment, it is more imperative than ever that our celiac community comes together to…
Continue ReadingThe Celiac Disease Foundation is pleased to announce the establishment of two international celiac disease research prizes to inspire a new generation of researchers whose work in celiac disease will be invaluable.
Continue ReadingThe Celiac Disease Foundation is in discussion with a team at the University of Colorado, Denver to develop the first-ever, FDA-approved pediatric PRO (patient-reported outcome tool).
Continue ReadingOn April 8 and April 9, the Celiac Disease Foundation is sponsoring the Columbia University Celiac Disease Center International Symposium on Celiac Disease.
Continue Reading